EC Number |
Activating Compound |
Reference |
---|
2.7.3.2 | panaxadiol |
15.4% increase of activity at 0.08 mM |
760706 |
2.7.3.2 | 24-carboxy-protopanaxadiol |
17.3% increase of activity at 0.005 mM |
760706 |
2.7.3.2 | 20(R)-protopanaxadiol |
23.5% increase of activity at 0.02 mM |
760706 |
2.7.3.2 | 25-hydroxy-protopanaxadiol |
23.5% increase of activity at 0.02 mM |
760706 |
2.7.3.2 | ginsenoside Rh2 |
3.5% increase of activity at 0.04 mM |
760706 |
2.7.3.2 | 20(S)-protopanaxatriol |
32.2% increase of activity at 0.02 mM |
760706 |
2.7.3.2 | ADP |
activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine |
674713 |
2.7.3.2 | ATP |
activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine |
674713 |
2.7.3.2 | Creatine |
activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine |
674713 |
2.7.3.2 | olanzapine |
activation of enzyme in striatum after chronic administration at 10 mg/kg |
671679 |